Metabolomic Profiling and Cardiovascular Outcomes in Patients with Cirrhotic Cardiomyopathy Undergoing Liver Transplantation
Not Applicable
Recruiting
- Conditions
- Cirrhotic cardiomyopathyOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCirrhosisLiver transplantationCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12624001166561
- Lead Sponsor
- Dr Madeleine Gill
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients undergoing assessment for liver transplantation at the Australian National Liver Transplant Unit at The Royal Prince Alfred Hospital will be prospectively recruited
Exclusion Criteria
- Patients with non-cirrhotic indications for liver transplant 2) Patients undergoing multi-organ transplantation 3) Patients with haemodynamically significant valvular heart disease, non-revascularised coronary artery disease, or any pre-existing non-cirrhotic cardiomyopathy 4) Patients with underlying liver diseases that can potentially cause infilitrative cardiovascular disease such as amyloidosis, sarcodosis, or haemochromotosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method